To demonstrate the added value of intraoperative pancreatoscopy in patients undergoing
partial pancreatic resection for the treatment of Intraductal Papillary Mucinous Neoplasm
(IPMN) as it pertains to detection of discontinuous (skip) lesions in the remnant
pancreas; to generate a hypothesis for a subsequent randomized control trial.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03729453.
The primary objective of this study is to demonstrate the added value of intraoperative
pancreatoscopy in patients undergoing partial pancreatic resection for the treatment of
Intraductal Papillary Mucinous Neoplasm (IPMN) as it pertains to detection of
discontinuous (skip) lesions in the remnant pancreas. A secondary study objective is to
generate a hypothesis for a subsequent randomized controlled trial comparing diagnostic
accuracy of intra-operative pancreatoscopy and SpyBite™ with the diagnostic accuracy of
intra-operative frozen section in patients undergoing resection
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationBoston Scientific Corporation
